Weekly SCD Practice Update

Outcomes of a Sustained Multi-Disciplinary Advisory Group in Advancing Sickle Cell Care and Research

Ifeanyi Beverly Chukwudozie, MBA, MPH, Judith M Nocek, PhD, Marwah Farooqui, DO, Patricia Lasley, MPH, Larissa Verda, MD, PhD, Eugenia Sanders, MD, Bridget Reynolds, Lewis L Hsu, MD, PhD, Victor R Gordeuk, MD, Abraham Wandersman, PhD, Kay L Saving, MD

Key Findings

  • Purpose
    To describe the outcomes of a sustained, collaborative, long-term multidisciplinary health provider andcommunity advisory group focused on improving sickle cell disease (SCD) care, education, and research.
  • Population (Model)
    The Clinical and Research AdvisoryGroup (CRAG) was established in 2016 as part of the NIH-funded Improving Sickle Cell Care in Adolescents & Adults in Chicago (ISAAC) initiative. Participants included researchers, healthcareproviders from four Illinois institutions, implementation science consultants, patients, andstakeholders, with additional collaboration involving partners in South Carolina.
  • Headline Result
    The sustained collaborationimproved communication among SCD researchers, healthcareproviders, patients, and stakeholders across Illinois. Key accomplishments included establishing a Community Advisory Board (CAB), increasing patient participation in researchplanning, supporting statewide carecoordination, launching the Annual Chicago Sickle Cell Summit, creating a monthly ECHO educational seminar, and fostering increased SCD-related presentations and publications.
  • Why It Matters

    Coordinating care and researchacross institutions remains a challenge in SCD. This study suggests that a long-term multidisciplinary advisory structure can support collaboration among clinicians, researchers, patients, andstakeholders while strengthening education, research engagement, and care coordination efforts.

  • Evidence Gaps & Limitations
    The study describes programmatic outcomes rather than patient-level clinical outcomes. It does not directly measure effects on healthcareutilization, disease complications, quality of life, or survival. Additional research is needed to determine whether similar advisory-groupmodels improve measurable clinical outcomes when implemented in other regions.

Source: Journal of Sickle Cell Disease- “Outcomes of a sustained multi-disciplinary advisory group in advancing sickle cell care and research”

Regulatory & Guideline Watch

Current SCD care frameworks emphasize multidisciplinary care, patient engagement, andcoordination across healthcaresettings. This study provides a real-world example of how sustained collaboration among providers, researchers, patients, andcommunity stakeholders may support these goals, suggesting a specific advisory-group model.

Stay Informed. Stay Empowered.

Subscribe to our newsletter for the latest updates on sickle cell research, events, and resources.

Get expert insights, patient stories, and ways to get involved, delivered straight to your inbox.

Join our community today!